Integrating High-Sensitivity Troponin T and Sacubitril/Valsartan Treatment in HFpEF

MLA

Gori, Mauro, et al. “Integrating High-Sensitivity Troponin T and Sacubitril/Valsartan Treatment in HFpEF.” JACC: Heart Failure, vol. 9, no. 9, Sept. 2021, pp. 627–35. EBSCOhost, https://doi.org/10.1016/j.jchf.2021.04.009.

APA

Gori, M., Senni, M., Claggett, B., Liu, J., Maggioni, A. P., Zile, M., Prescott, M. F., Van Veldhuisen, D. J., Zannad, F., Pieske, B., Lam, C. S. P., Rouleau, J., Jhund, P., Packer, M., Pfeffer, M. A., Lefkowitz, M., Shi, V., McMurray, J. J. V., & Solomon, S. D. (2021). Integrating High-Sensitivity Troponin T and Sacubitril/Valsartan Treatment in HFpEF. JACC: Heart Failure, 9(9), 627–635. https://doi.org/10.1016/j.jchf.2021.04.009

Chicago

Gori, Mauro, Michele Senni, Brian Claggett, Jiankang Liu, Aldo P. Maggioni, Michael Zile, Margaret F. Prescott, et al. 2021. “Integrating High-Sensitivity Troponin T and Sacubitril/Valsartan Treatment in HFpEF.” JACC: Heart Failure 9 (9): 627–35. doi:10.1016/j.jchf.2021.04.009.